acoustic

Latest content

25Jan

Redenlab’s Chief Science Officer, Adam P. Vogel, PhD, leads groundbreaking study on speech analysis for neurodegenerative diseases

MEDIA RELEASE Melbourne, 19 January 2024 — Redenlab, a leader in innovative healthcare solutions, ispleased to announce a…

31Jul

Redenlab commence work with Melbourne Brain Centre & The University of Melbourne on speech testing for clinical trial in Dravet Syndrome

acoustic

For more information

Contact Us

If you are interested in seeing how Redenlab can help your organisation, please fill in the form and we’ll get in contact with you.